Hangzhou Jitai Pharmaceutical is the world's first startup company to drive the development of pharmaceutical preparations with artificial intelligence. The team combines high-throughput preparation platforms and artificial intelligence computing and other technologies to provide pharmaceutical companies with rapid and accurate intelligent preparation research and development. Hangzhou YaoJitai Medicine is a top Chinese and American team composed of academicians of the American Academy of Engineering and a number of MIT scientists. In addition to high-end formulation research and development technology, it also has unique experience in clinical trials and FDA approval. The team invested millions of dollars from Fengrui and source code capital to develop new drugs for cancer and infectious diseases and bring high-quality and efficient drugs to patients.